In the same experiments, we found that it was irrelevant for the outcome whether the melanoma cell lines that acted as MART-1 antigen donor expressed HLA-A2, in agreement with the notion that the HLA-A2+ DC crosspresented the antigen. This evidence concerns the gene MLANA and melanoma.